What Is The Gabelli Healthcare & Wellne (GRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on The Gabelli Healthcare & Wellne at its current price of $9.48. The composite intrinsic value is estimated at $7.29 (-23.1% average return), with 5 models flagging overvaluation risk. Notably, First Chicago sees the most upside at +17.3% (fair value: $11.12), while Bayesian DCF is the most conservative at -75.2% ($2.35). The spread between these extremes — +92.5% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About GRX?
7 of 13 models are currently active for GRX. Of these, 2 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates GRX's intrinsic value at $2.35, implying -75.2% downside from the current price. See which stocks rank higher →
How Does GRX Rank in —?
GRX operates in the — sector. CirclFi's QOC score of 2.1/10 evaluates 32 fundamental signals. A score of 2.1 signals below-average fundamentals.
The Gabelli Healthcare & Wellne operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is GRX a Value Trap?
The Value Trap algorithm is not active for GRX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for The Gabelli Healthcare & Wellne. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, The Gabelli Healthcare & Wellne is rated at 2.1/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.
The gap between the most bullish and bearish model spans +92.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GRX's 7 active models, average confidence is 3%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad